ATE305044T1 - Lgmd- gen kodierend für einer calcium abhängigen protease - Google Patents
Lgmd- gen kodierend für einer calcium abhängigen proteaseInfo
- Publication number
- ATE305044T1 ATE305044T1 AT95938456T AT95938456T ATE305044T1 AT E305044 T1 ATE305044 T1 AT E305044T1 AT 95938456 T AT95938456 T AT 95938456T AT 95938456 T AT95938456 T AT 95938456T AT E305044 T1 ATE305044 T1 AT E305044T1
- Authority
- AT
- Austria
- Prior art keywords
- sequence
- calcium
- lgmd
- gene coding
- dependent protease
- Prior art date
Links
- 101710155556 Calcium-dependent protease Proteins 0.000 title 1
- 201000009342 Limb-girdle muscular dystrophy Diseases 0.000 title 1
- 108091005804 Peptidases Proteins 0.000 abstract 2
- 239000004365 Protease Substances 0.000 abstract 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 abstract 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract 1
- 102100032539 Calpain-3 Human genes 0.000 abstract 1
- 101000867715 Homo sapiens Calpain-3 Proteins 0.000 abstract 1
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 238000007792 addition Methods 0.000 abstract 1
- 229910052791 calcium Inorganic materials 0.000 abstract 1
- 239000011575 calcium Substances 0.000 abstract 1
- 230000037430 deletion Effects 0.000 abstract 1
- 238000012217 deletion Methods 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 150000007523 nucleic acids Chemical group 0.000 abstract 1
- 239000002773 nucleotide Substances 0.000 abstract 1
- 125000003729 nucleotide group Chemical group 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 238000006467 substitution reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6472—Cysteine endopeptidases (3.4.22)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP94402668A EP0717110A1 (de) | 1994-11-22 | 1994-11-22 | LGMD-Gen |
| PCT/EP1995/004575 WO1996016175A2 (en) | 1994-11-22 | 1995-11-21 | Lgmd gene coding for a calcium dependent protease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE305044T1 true ATE305044T1 (de) | 2005-10-15 |
Family
ID=8218064
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT95938456T ATE305044T1 (de) | 1994-11-22 | 1995-11-21 | Lgmd- gen kodierend für einer calcium abhängigen protease |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US6846623B1 (de) |
| EP (2) | EP0717110A1 (de) |
| JP (1) | JPH11500603A (de) |
| AT (1) | ATE305044T1 (de) |
| CA (1) | CA2204512C (de) |
| DE (1) | DE69534470T2 (de) |
| ES (1) | ES2250976T3 (de) |
| WO (1) | WO1996016175A2 (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2723378B1 (fr) * | 1994-08-02 | 1996-10-31 | Roussel Uclaf | Sequence d'adn codant pour une proteine humaine tx apparentee a l'enzyme de conversion de l'interleukine-1beta, proteine tx, procede de production, compositions pharmaceutiques et leurs applications |
| SE521936C2 (sv) * | 1996-06-26 | 2003-12-23 | Telia Ab | Metod för att effektivt använda bandbredd vid tillhandahållande av tjänster via ett digitalt cellulärt radiokommunikationssystem |
| IL129909A0 (en) * | 1996-12-04 | 2000-02-29 | Basf Ag | Novel calpaines their production and use thereof |
| EP0972830A4 (de) * | 1997-02-21 | 2003-02-05 | Takara Shuzo Co | Krebs-assoziierte gene |
| CA2321270A1 (en) | 1998-03-02 | 1999-09-10 | Senju Pharmaceutical Co., Ltd. | Novel calpain and dna encoding the same |
| US7098192B2 (en) | 1999-04-08 | 2006-08-29 | Isis Pharmaceuticals, Inc. | Antisense oligonucleotide modulation of STAT3 expression |
| WO2001016336A1 (en) | 1999-09-02 | 2001-03-08 | Lexicon Genetics Incorporated | Human calcium dependent proteases and polynucleotides encoding the same |
| CA2416691A1 (en) * | 2000-07-21 | 2002-01-31 | Incyte Genomics, Inc. | Proteases |
| EP1581647A4 (de) * | 2002-12-17 | 2007-04-18 | Univ Utah Res Found | Schnelle direkte sequenzanalyse von multi-exon-genen |
| CN103562215B (zh) | 2011-04-01 | 2017-04-26 | 埃西斯药品公司 | 信号转导及转录激活蛋白3(stat3)表达的调节 |
| FR3004463A1 (fr) | 2013-04-11 | 2014-10-17 | Genethon | Systeme d'expression pour une therapie genique selective |
-
1994
- 1994-11-22 EP EP94402668A patent/EP0717110A1/de not_active Withdrawn
-
1995
- 1995-11-21 DE DE69534470T patent/DE69534470T2/de not_active Expired - Lifetime
- 1995-11-21 US US08/836,734 patent/US6846623B1/en not_active Expired - Fee Related
- 1995-11-21 JP JP8516572A patent/JPH11500603A/ja active Pending
- 1995-11-21 WO PCT/EP1995/004575 patent/WO1996016175A2/en not_active Ceased
- 1995-11-21 CA CA2204512A patent/CA2204512C/en not_active Expired - Fee Related
- 1995-11-21 EP EP95938456A patent/EP0792364B1/de not_active Expired - Lifetime
- 1995-11-21 ES ES95938456T patent/ES2250976T3/es not_active Expired - Lifetime
- 1995-11-21 AT AT95938456T patent/ATE305044T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0792364B1 (de) | 2005-09-21 |
| US6846623B1 (en) | 2005-01-25 |
| ES2250976T3 (es) | 2006-04-16 |
| DE69534470D1 (de) | 2006-02-02 |
| EP0717110A1 (de) | 1996-06-19 |
| CA2204512C (en) | 2010-08-24 |
| WO1996016175A2 (en) | 1996-05-30 |
| JPH11500603A (ja) | 1999-01-19 |
| DE69534470T2 (de) | 2006-06-14 |
| EP0792364A2 (de) | 1997-09-03 |
| CA2204512A1 (en) | 1996-05-30 |
| WO1996016175A3 (en) | 1996-10-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2153037T3 (es) | Lacasas purificadas de scytalidium y acidos nucleicos que las codifican. | |
| PT765394E (pt) | Lacases myceliophthora purificadas e acidos nucleicos que as codificam | |
| ATE399857T1 (de) | Computer vermitteltes assembly von polynucleotiden kodierend für ein zielgerichtetes polypeptide | |
| PT839196E (pt) | Ctla-8 humana e utilizacoes de proteinas relacionadas com ctla-8 | |
| MX9705727A (es) | Variantes de amilasa. | |
| ATE305044T1 (de) | Lgmd- gen kodierend für einer calcium abhängigen protease | |
| DK72992D0 (da) | Enzym | |
| DE3889838D1 (de) | Strichkode-Abtastkopf. | |
| DK0475291T3 (da) | Fra kylling afledt biologisk aktivt peptid (kylling CNP) | |
| LU90781I2 (fr) | Fasturtec -rasburicase | |
| DK0592836T3 (da) | DNA af integrationsstedet for humant adenoassocieret virus og dets anvendelse | |
| DK0601154T3 (da) | BPC-peptider, deres fremstilling og anvendelse | |
| DK346385A (da) | Genetiske sekvenser, hermed kodede interferon-peptider af type i og organismer, der producerer disse | |
| ATE264913T1 (de) | Protease-resistente analoge des thrombomodulin | |
| DE69532033D1 (de) | Für ein fibroblasten-aktivierungsprotein kodierende nukleinsäure und verwendungen dafür | |
| AR053931A2 (es) | Secuencia de adn que codifica una proteina de a. thaliana que posee actividad de delta -5,7-esterol, delta-7-reductasa, proteina delta-7red | |
| CY1107297T1 (el) | Συνθεση με μυκητοκτονο δραση με βαση αλας καλιου του φωσφορωδους οξεος (potassium acid phosphite) | |
| ATE142702T1 (de) | Spezifischer nachweis von mycobacterium tuberculosis | |
| ATE166656T1 (de) | Humanes galanin, cdna-klone die für humanes galanin kodieren und eine methode humanes galamin herzustellen | |
| BR9506038A (pt) | Dna clonato vetor recombinante e planta | |
| ATE103166T1 (de) | Haarbehandlungszusammensetzung. | |
| FI922865A0 (fi) | Kollagen-bindande protein samt dess framstaellning. | |
| NO971508L (no) | Analoger av sur fibroblastvekstfaktor med forökt stabilitet og biologisk aktivitet | |
| ATE412751T1 (de) | Menschliche tak1 und für diese kodierende dna | |
| DE69534596D1 (de) | Epil/plazentin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |